Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 1

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(4)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07355140Not ApplicableCompleted

Vital Pulp Therapy vs. Root Canal Treatment in Mature Teeth With Irreversible Pulpitis

Role: lead

NCT06294470Not ApplicableCompleted

Efficacy of Stapled Hemorrhoidopexy for the Treatment of Obstructive Defecation Syndrome

Role: lead

NCT05975892Phase 1Unknown

Transplantation of Bone Marrow Mesenchymal Stromal Cells for Periodontal Regeneration

Role: collaborator

NCT04545307Phase 2Completed

Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis

Role: lead

NCT02765087Not ApplicableUnknown

E-Nose: Diagnostic Tool for Pleural TB

Role: lead

NCT02226627Completed

Latin American Survey of Nutrition and Health / Estudio Latinoamericano de Nutrición y Salud

Role: collaborator

NCT02768909Not ApplicableUnknown

Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB

Role: lead

All 7 trials loaded